Cordant Inc’s Zimmer Biomet ZBH Stock Holding History

Cordant Inc’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-29	Closed	-$4K	–	1291
2022 Q1	$4K	Buy	+29	New	+$3.5K	﹤0.01%	413

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cordant Inc's ZBH Position: Q2 2022 in Review

Cordant Inc sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 29 shares — an estimated $4K sold.

Cordant Inc first reported a position in ZBH in Q1 2022 and held it in 1 quarter. The position peaked at $4K in Q1 2022. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

Cordant Inc reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 29 Zimmer Biomet shares in Q2 2022, an estimated $4K.
Cordant Inc first reported a position in Zimmer Biomet in Q1 2022 and held it in 1 quarter.
Cordant Inc's Zimmer Biomet position peaked at $4K in Q1 2022.
956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.